- Home
- Publications
- Publication Search
- Publication Details
Title
Fighting Post-COVID and ME/CFS – development of curative therapies
Authors
Keywords
-
Journal
Frontiers in Medicine
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2023-06-15
DOI
10.3389/fmed.2023.1194754
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efgartigimod improved health-related quality of life in generalized myasthenia gravis: results from a randomized, double-blind, placebo-controlled, phase 3 study (ADAPT)
- (2023) Francesco Saccà et al. JOURNAL OF NEUROLOGY
- Long COVID: major findings, mechanisms and recommendations
- (2023) Hannah E. Davis et al. NATURE REVIEWS MICROBIOLOGY
- Endothelial dysfunction in ME/CFS patients
- (2023) Miriam Kristine Sandvik et al. PLoS One
- Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome
- (2023) Christiana Franke et al. BRAIN BEHAVIOR AND IMMUNITY
- Myalgic Encephalomyelitis/Chronic Fatigue Syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): Results from a post-COVID-19 multidisciplinary clinic
- (2023) Hector Bonilla et al. Frontiers in Neurology
- Structural brain changes in patients with post-COVID fatigue: a prospective observational study
- (2023) Josephine Heine et al. EClinicalMedicine
- Multiple Early Factors Anticipate Post-Acute COVID-19 Sequelae
- (2022) Yapeng Su et al. CELL
- Long COVID‐19: Objectifying most self‐reported neurological symptoms
- (2022) Julia Bungenberg et al. Annals of Clinical and Translational Neurology
- Neurovascular Dysregulation and Acute Exercise Intolerance in ME/CFS: A Randomized, Placebo-Controlled Trial of Pyridostigmine
- (2022) Phillip Joseph et al. CHEST
- Inflammation, immunity, and antigen persistence in post-acute sequelae of SARS-CoV-2 infection
- (2022) Krista L. Newell et al. CURRENT OPINION IN IMMUNOLOGY
- Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS)
- (2022) Milan Haffke et al. Journal of Translational Medicine
- Unexplained post-acute infection syndromes
- (2022) Jan Choutka et al. NATURE MEDICINE
- Long COVID after breakthrough SARS-CoV-2 infection
- (2022) Ziyad Al-Aly et al. NATURE MEDICINE
- Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort
- (2022) Viet-Thi Tran et al. Nature Communications
- The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics
- (2022) Maximilian Schons et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study
- (2022) Aranka V Ballering et al. LANCET
- Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
- (2022) Obbina Abani et al. LANCET
- Long-COVID treatments: why the world is still waiting
- (2022) Heidi Ledford NATURE
- Symptoms and risk factors for long COVID in non-hospitalized adults
- (2022) Anuradhaa Subramanian et al. NATURE MEDICINE
- Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial
- (2022) Shani Zilberman-Itskovich et al. Scientific Reports
- Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long-COVID symptoms
- (2022) Kiho Son et al. EUROPEAN RESPIRATORY JOURNAL
- A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity
- (2022) Claudia Kedor et al. Nature Communications
- Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity
- (2022) Franziska Sotzny et al. Frontiers in Immunology
- Value of montelukast as a potential treatment of post-COVID-19 persistent cough: a non-randomized controlled pilot study
- (2022) Aliae A. R. Mohamed Hussein et al. The Egyptian Journal of Bronchology
- Nebivolol: an effective option against long-lasting dyspnoea following COVID-19 pneumonia - a pivotal double-blind, cross-over controlled study
- (2022) Roberto W. Dal Negro et al. Multidisciplinary Respiratory Medicine
- Post-COVID-19-associated morbidity in children, adolescents, and adults: A matched cohort study including more than 157,000 individuals with COVID-19 in Germany
- (2022) Martin Roessler et al. PLOS MEDICINE
- Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients
- (2021) Anna C. Aschenbrenner et al. Genome Medicine
- Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole
- (2021) L. D. Crosby et al. Journal of Translational Medicine
- Small molecule approaches to treat autoimmune and inflammatory diseases (Part I): Kinase inhibitors
- (2021) Jiamin Zheng et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Skewing of the B cell receptor repertoire in myalgic encephalomyelitis/chronic fatigue syndrome
- (2021) Wakiro Sato et al. BRAIN BEHAVIOR AND IMMUNITY
- Hand grip strength and fatigability: correlation with clinical parameters and diagnostic suitability in ME/CFS
- (2021) Bianka Jäkel et al. Journal of Translational Medicine
- Oral Minocycline Therapy Improves Symptoms of Myalgic Encephalomyelitis, Especially in the Initial Disease Stage
- (2021) Kunihisa Miwa INTERNAL MEDICINE
- Persistent symptoms following SARS-CoV-2 infection amongst children and young people: A meta-analysis of controlled and uncontrolled studies
- (2021) S.A. Behnood et al. JOURNAL OF INFECTION
- Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines
- (2021) Paul Glynne et al. JOURNAL OF INVESTIGATIVE MEDICINE
- A Short Corticosteroid Course Reduces Symptoms and Immunological Alterations Underlying Long-COVID
- (2021) Alberto Utrero-Rico et al. Biomedicines
- A Three-Part, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Mode of Action of BC 007, Neutraliser of Pathogenic Autoantibodies Against G-Protein Coupled Receptors in Healthy, Young and Elderly Subjects
- (2020) Niels-Peter Becker et al. CLINICAL DRUG INVESTIGATION
- Autoimmunity-Related Risk Variants in PTPN22 and CTLA4 Are Associated With ME/CFS With Infectious Onset
- (2020) Sophie Steiner et al. Frontiers in Immunology
- Severe COVID-19 is marked by a dysregulated myeloid cell compartment
- (2020) Jonas Schulte-Schrepping et al. CELL
- Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection
- (2020) Christoph B. Messner et al. Cell Systems
- Risks for Developing ME/CFS in College Students Following Infectious Mononucleosis: A Prospective Cohort Study
- (2020) Leonard A Jason et al. CLINICAL INFECTIOUS DISEASES
- Neuroinflammation and Cytokines in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Critical Review of Research Methods
- (2019) Michael B. VanElzakker et al. Frontiers in Neurology
- B-Lymphocyte Depletion in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
- (2019) Øystein Fluge et al. ANNALS OF INTERNAL MEDICINE
- Cytokine signature associated with disease severity in chronic fatigue syndrome patients
- (2017) Jose G. Montoya et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Long-term methylphenidate intake in chronic fatigue syndrome
- (2016) Daniel Blockmans et al. ACTA CLINICA BELGICA
- Distinct plasma immune signatures in ME/CFS are present early in the course of illness
- (2015) M. Hornig et al. Science Advances
- B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment
- (2015) Øystein Fluge et al. PLoS One
- Use of lisdexamfetamine dimesylate in treatment of executive functioning deficits and chronic fatigue syndrome: A double blind, placebo-controlled study
- (2012) Joel L. Young PSYCHIATRY RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started